Indaptus Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INDP and other ETFs, options, and stocks.

About INDP

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. 

CEO
Jeffrey A. Meckler
CEOJeffrey A. Meckler
Employees
7
Employees7
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
Founded
Employees
7
Employees7

INDP Key Statistics

Market cap
7.84M
Market cap7.84M
Price-Earnings ratio
-0.34
Price-Earnings ratio-0.34
Dividend yield
Dividend yield
Average volume
37.09M
Average volume37.09M
High today
$0.8969
High today$0.8969
Low today
$0.42
Low today$0.42
Open price
$0.5554
Open price$0.5554
Volume
365.36M
Volume365.36M
52 Week high
$2.42
52 Week high$2.42
52 Week low
$0.2701
52 Week low$0.2701

People also own

Based on the portfolios of people who own INDP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.